News
11-15-2012, 04:10 AM
Heart failure is a relatively common complication in older women with breast cancer, but the risk is even higher in those patients treated with adjuvant trastuzumab (Herceptin-), Yale School of Medicine researchers report in the current issue of the Journal of the American College of Cardiology.
More... (http://www.news-medical.net/news/20121115/Trastuzumab-increases-risk-of-heart-failure-in-older-women-with-breast-cancer.aspx)
More... (http://www.news-medical.net/news/20121115/Trastuzumab-increases-risk-of-heart-failure-in-older-women-with-breast-cancer.aspx)